company background image
ALIMP logo

Implanet ENXTPA:ALIMP Stock Report

Last Price

€0.10

Market Cap

€12.5m

7D

-0.5%

1Y

-10.3%

Updated

29 May, 2025

Data

Company Financials

ALIMP Stock Overview

A medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. More details

ALIMP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Implanet S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Implanet
Historical stock prices
Current Share Price€0.10
52 Week High€0.15
52 Week Low€0.083
Beta0.96
1 Month Change-1.19%
3 Month Change-11.50%
1 Year Change-10.31%
3 Year Change-60.16%
5 Year Change-93.05%
Change since IPO-99.97%

Recent News & Updates

We Think Implanet (EPA:ALIMP) Has A Fair Chunk Of Debt

Oct 08
We Think Implanet (EPA:ALIMP) Has A Fair Chunk Of Debt

Recent updates

We Think Implanet (EPA:ALIMP) Has A Fair Chunk Of Debt

Oct 08
We Think Implanet (EPA:ALIMP) Has A Fair Chunk Of Debt

Implanet (EPA:ALIMP) Is Carrying A Fair Bit Of Debt

Mar 21
Implanet (EPA:ALIMP) Is Carrying A Fair Bit Of Debt

Shareholder Returns

ALIMPFR Medical EquipmentFR Market
7D-0.5%-5.1%-1.1%
1Y-10.3%21.1%-4.2%

Return vs Industry: ALIMP underperformed the French Medical Equipment industry which returned 21.9% over the past year.

Return vs Market: ALIMP underperformed the French Market which returned -3.5% over the past year.

Price Volatility

Is ALIMP's price volatile compared to industry and market?
ALIMP volatility
ALIMP Average Weekly Movement5.8%
Medical Equipment Industry Average Movement5.2%
Market Average Movement5.4%
10% most volatile stocks in FR Market11.3%
10% least volatile stocks in FR Market2.7%

Stable Share Price: ALIMP has not had significant price volatility in the past 3 months compared to the French market.

Volatility Over Time: ALIMP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200646Ludovic Lastennetwww.implanet.com

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation.

Implanet S.A. Fundamentals Summary

How do Implanet's earnings and revenue compare to its market cap?
ALIMP fundamental statistics
Market cap€12.50m
Earnings (TTM)-€5.22m
Revenue (TTM)€9.41m
1.3x
P/S Ratio
-2.4x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALIMP income statement (TTM)
Revenue€9.41m
Cost of Revenue€5.31m
Gross Profit€4.10m
Other Expenses€9.32m
Earnings-€5.22m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Sep 16, 2025

Earnings per share (EPS)-0.042
Gross Margin43.58%
Net Profit Margin-55.45%
Debt/Equity Ratio718.0%

How did ALIMP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 00:19
End of Day Share Price 2025/05/29 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Implanet S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christophe Dombu YoutaAurgalys SAS
Jean-Pierre LozaIn Extenso Financement & Marché
Sébastien MalafosseODDO BHF Corporate & Markets